|
|
|
|
|
01.04.26 - 13:36
|
DuPont Completes Divestiture of Aramids Business (PR Newswire)
|
|
|
WILMINGTON, Del., April 1, 2026 /PRNewswire/ -- DuPont (NYSE:DD) today announced it has completed the previously-announced divestiture of its Aramids business (Kevlar® and Nomex®) to Arclin, a portfolio company of an affiliate of TJC, L.P. (TJC), in a transaction valuing the business at......
|
|
|
01.04.26 - 13:33
|
DAX-Verlierer: Symrise Aktie unter Druck - Chance auf Rebound? (Aktiencheck)
|
|
|
Frankfurt (www.aktiencheck.de) - Symrise-Aktienanalyse von XTB:
Die Experten von XTB nehmen die Aktie der Symrise AG (ISIN: DE000SYM9999, WKN: SYM999, Ticker-Symbol: SY1, NASDAQ OTC-Symbol: SYIEF) unter die Lupe.
Per Xetra-Schluss vom 31.03.2026 hätten 34 Aktien im Plus notiert, während lediglich 6 Werte Verluste verzeichnet hätten. [mehr]...
|
|
|
01.04.26 - 13:03
|
Avient to Hold First Quarter 2026 Conference Call (PR Newswire)
|
|
|
CLEVELAND, April 1, 2026 /PRNewswire/ -- Avient Corporation (NYSE: AVNT), an innovator of materials solutions, intends to release its first quarter 2026 earnings before the market opens on Thursday, May 7, 2026. The company will then host a webcast with a slide presentation at 8:00 a.m.......
|
|
|
01.04.26 - 13:01
|
Evonik-Chef Kullmann zieht Kritik am CO₂-Handel zurück (Tichys Einblick)
|
|
|
Fünf Monate sind im Mediengeschäft eine Ewigkeit. Und es scheint tatsächlich eine Ewigkeit vergangen zu sein, seit Christian Kullmann, seines Zeichens CEO des deutschen Chemiekonzerns Evonik, Ende Oktober mit der europäischen Klimapolitik hart ins Gericht ging. Kullmann gab seinerzeit der Süddeutschen Zeitung ein Interview, in dem er, wenn nicht gar das Aus, so doch zumindest
Der Beitrag Evonik-Chef Kullmann zieht Kritik am CO₂-Handel zurück erschien zuerst auf Tichys Einblick....
|
|
|
|
|
01.04.26 - 12:51
|
RPM Declares Quarterly Dividend (Business Wire)
|
|
|
MEDINA, Ohio--(BUSINESS WIRE)--RPM International Inc. (NYSE: RPM) today announced that its board of directors declared a regular quarterly cash dividend of $0.54 per share, payable on April 30, 2026, to stockholders of record as of April 16, 2026.
RPM's last cash dividend increase of 6% in October 2025 marked RPM's 52nd consecutive year of increased cash dividends paid to its stockholders, which places RPM in an elite category of less than half of 1 percent of all publicly traded U.S. companies. Only 39 other U.S. companies have consecutively paid an increasing annual dividend for a longer period of time, according to stockanalysis.com. During this timeframe, the company has returned approximately $3.9 billion in cash dividends to its stockholders.
About RPM
RPM International Inc. owns subsidiaries that are world leaders in specialty coatings, sealants, building materials and related services. The company operates across three reportable segments: consumer, construction products and performance coatings...
|
|
|
01.04.26 - 12:51
|
RPM Completes Acquisition of Kalzip (Business Wire)
|
|
|
Acquisition Strengthens RPM's Global Building Envelope Portfolio and Enhances Market Presence in Europe and BeyondMEDINA, Ohio--(BUSINESS WIRE)--RPM International Inc. (NYSE:RPM) today announced that it has completed the previously announced acquisition of Kalzip GmbH (“Kalzip”), a global leader in the design and production of metal-based roofs and facades for building envelopes, for its Tremco Construction Products Group (“Tremco CPG”).
Kalzip is a globally recognized leader in aluminum roofing and façade systems. Headquartered in Koblenz, Germany, the company specializes in customized lightweight, weather-resistant building envelope technologies. Delivering over 1.2 billion square feet of aluminum solutions worldwide, key projects have included Estadio Santiago Bernabéu football stadium in Madrid, Children's Hospital in Dublin, Pickering GO Pedestrian Bridge in Canada, and the LAX Train Station in Los Angeles.
Kalzip generated calendar year 2024 net sales of approximately €75 million; term...
|
|
|
|
|
01.04.26 - 12:30
|
Dealings in Securities by the AECI Limited Long Term Incentive Scheme (Cision)
|
|
|
AECI LIMITED
(Incorporated in the Republic of South Africa)
Registration number: 1924/002590/06
Share code: AFE ISIN: ZAE000000220
Hybrid code: AFEP ISIN: ZAE000000238
Bond company code: AECI
LEI: 3789008641F1D3D90E85
(AECI)
DEALINGS IN SECURITIES BY THE AECI LIMITED LONG TERM INCENTIVE SCHEME (SCHEME)
In accordance with paragraphs 6.78 to 6.90 of the JSE Listings Requirements, AECI shareholders and noteholders are advised of the following acquisitions of AECI ordinary shares (Shares) on behalf of the Scheme (Acquisitions):
+-----+------+---------...
|
|
|
|
|
01.04.26 - 12:01
|
Addition of Non-Executive Director to TP Aerospace (Cision)
|
|
|
Copenhagen, April 1, 2026 – At an extraordinary general assembly held today, the shareholders of TP Aerospace resolved to appoint Tilde Kejlhof as a new member of the Board of Directors.
Tilde Kejlhof brings extensive experience in finance and production. She joins from SP Group, a company listed on the Copenhagen Stock Exchange, where she currently serves as Senior Vice President with a focus on strategic projects. Prior to this role, she held the position of Chief Financial Officer.
Tilde Kejlhof will also assume the role of Chair of the Audit Committee.
TP Aerospace welcomes...
|
|
|
01.04.26 - 12:01
|
LANXESS Neutral (DPA-AFX)
|
|
|
NEW YORK (dpa-AFX Analyser) - Die US-Investmentbank Goldman Sachs hat das Kursziel für Lanxess vor Zahlen zum ersten Quartal von 23 auf 21 Euro gesenkt und die Einstufung auf "Neutral" belassen. Mit ihrer neuen Schätzung für das operative Ergebnis (Ebitda) ......
|
|
|
01.04.26 - 11:57
|
BASF Neutral (DPA-AFX)
|
|
|
ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat das Kursziel für BASF von 47 auf 52 Euro angehoben, aber die Einstufung auf "Neutral" belassen. Mit Blick auf die Quartalszahlen des Chemiekonzerns am 30. April liege seine operative Ergebnisschätzung ......
|
|
|
01.04.26 - 11:15
|
Mosaic Therapeutics appoints Dr Vince O′Neill, MD, as Head of R&D (Business Wire)
|
|
|
- Medical oncologist and accomplished clinical leader brings deep development and industry experience to Mosaic's Executive Leadership team
- Vince will lead research and development for Mosaic's drug combination programs, including the build-out of the Company's early pipelineCAMBRIDGE, England--(BUSINESS WIRE)--Mosaic Therapeutics, Ltd, ('Mosaic', or 'the Company') a clinical-stage oncology therapeutics company developing next-generation, Synergistic Precision combination therapies, today announced the appointment of Dr Vince O'Neill as Head of Research and Development (R&D) to support its next phase of growth.
“We are delighted to welcome Vince to the Mosaic leadership team at this pivotal stage of the company's evolution,” said Thomas Fuchs, CEO, Mosaic Therapeutics. “His deep expertise in targeted oncology drug development and diagnostics will be instrumental as we advance our pipeline to bring transformative therapies to patients in need.”
Vince is a board-certified medical oncologi...
|
|
|
|
|
01.04.26 - 09:06
|
BASF: Kleiner Boden, großer Boden? Chartanalyse (Aktiencheck)
|
|
|
Düsseldorf (www.aktiencheck.de) - BASF-Chartanalyse von HSBC Trinkaus & Burkhardt:
Die Analysten von HSBC Trinkaus & Burkhardt nehmen in einer aktuellen Aktienanalyse die Aktie der BASF SE (ISIN: DE000BASF111, WKN: BASF11, Ticker-Symbol: BAS, NASDAQ OTC-Symbol: BFFAF) charttechnisch unter die Lupe
In den letzten Jahren sei mit der BASF-Aktie kein Staat zu machen gewesen. [mehr]...
|
|
|
01.04.26 - 09:06
|
Ganfeng Lithium forecasts strong battery demand amid China-US rivalry in renewable energy (SCMP)
|
|
|
China's Ganfeng Lithium, the world's largest producer of lithium metal, is envisioning an “explosive growth” in the global energy storage system (ESS) market in 2026, spurred by higher prices of the key battery material and buoyant demand for renewable energy infrastructure.
Executives including president Wang Xiaoshen told an investors' conference on Tuesday that the global decarbonisation drive had created a strong and sustainable trajectory for Ganfeng, which swung from loss to profit last......
|
|
|
01.04.26 - 09:03
|
Serstech publicerar årsredovisningen för 2025 (GlobeNewswire EN)
|
|
|
Serstech AB (publ) meddelar att årsredovisningen för 2025 nu finns tillgänglig på bolagets webbplats, www.serstech.com. Årsredovisningen finns även bifogad i detta pressmeddelande.För mer information:Stefan Sandor, VD Serstech ABTelefon: 0739-60 60 67E-post: ss@serstech.comellerThomas Pileby, Styrelseordförande Serstech ABTelefon: 0702-07 26 43E-post: tp@serstech.comeller besök: www.serstech.comCertified advisor åt Serstech är Svensk Kapitalmarknadsgranskning AB (SKMG).Om SerstechSerstech utvecklare och säljer utrustning för identifiering av farliga kemikalier, såsom narkotika, bomber och kemiska stridsmedel. Bolagets kunder är huvudsakligen rättsvårdande myndigheter och inkluderar FN, Världstullorganisationen (WCO) och tull- och polismyndigheter över hela världen. Serstech har återförsäljare i 63 länder. Bolaget har huvudkontor i Lund och all tillverkning sker i Sverige.Serstech är listat på Nasdaq First North Growth Market. Mer information finns på www.serstech.com...
|
|
|
01.04.26 - 08:12
|
BASF: "Hype"? Das drückt auf die Stimmung! (Der Aktionaer)
|
|
|
Die Anteile des Chemie-Riesen BASF ist im Laufe der Handelswoche auf ein neues 52-Wochen-Hoch geklettert – und das trotz der ganzen geopolitischen Risiken. Doch die Analysten von Kepler Cheuvreux treten auf die Euphorie-Bremse: Am Dienstag strich das Research-Haus die Kaufempfehlung für den Blue Chip....
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
